Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25
Lloyds Banking Group plc provides banking and financial services under the Lloyds Bank, Halifax, Bank of Scotland, and Scottish Widows brands in the United Kingdom and internationally. The company operates through three segments: Retail, Commercial Banking, and Insurance and Wealth. The Retail segment offers a range of financial service products, including current accounts, savings accounts, mort… Read more
Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25 (LLOBF) - Net Assets
Latest net assets as of September 2024: $46.42 Billion USD
Based on the latest financial reports, Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25 (LLOBF) has net assets worth $46.42 Billion USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($900.84 Billion) and total liabilities ($854.42 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $46.42 Billion |
| % of Total Assets | 5.15% |
| Annual Growth Rate | -0.58% |
| 5-Year Change | -14.67% |
| 10-Year Change | N/A |
| Growth Volatility | 408.53 |
Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25 - Net Assets Trend (2014–2023)
This chart illustrates how Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25 (2014–2023)
The table below shows the annual net assets of Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25 from 2014 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $47.37 Billion | -0.33% |
| 2022-12-31 | $47.52 Billion | -94.07% |
| 2021-12-31 | $801.87 Billion | +4.19% |
| 2020-12-31 | $769.61 Billion | +1286.51% |
| 2019-12-31 | $55.51 Billion | +10.57% |
| 2018-12-31 | $50.20 Billion | +2.15% |
| 2017-12-31 | $49.14 Billion | +1.40% |
| 2016-12-31 | $48.47 Billion | +3.16% |
| 2015-12-31 | $46.98 Billion | -5.86% |
| 2014-12-31 | $49.90 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 19.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $6.79 Billion | 14.40% |
| Common Stock | $6.36 Billion | 13.48% |
| Other Comprehensive Income | $15.45 Billion | 32.75% |
| Other Components | $18.57 Billion | 39.37% |
| Total Equity | $47.16 Billion | 100.00% |
Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25 Competitors by Market Cap
The table below lists competitors of Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
B+S BANKSYSTEME - Dusseldorf Stock Exchang
DU:DTD2
|
$18.86K |
|
UNISYS (USY1.SG)
STU:USY1
|
$18.86K |
|
BDO Unibank Inc
PSE:BDO
|
$18.87K |
|
Makolab
WAR:MLB
|
$18.87K |
|
El-Nile Co. For Pharmaceuticals And Chemical Industries
EGX:NIPH
|
$18.84K |
|
Jammin Java Corp
PINK:JAMN
|
$18.84K |
|
Coplus Inc.
TW:2254
|
$18.83K |
|
NuRAN Wireless Inc
PINK:NRRWF
|
$18.78K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 47,277,000,000 to 47,164,000,000, a change of -113,000,000 (-0.2%).
- Net income of 5,460,000,000 contributed positively to equity growth.
- Dividend payments of 1,651,000,000 reduced retained earnings.
- Share repurchases of 1,993,000,000 reduced equity.
- New share issuances of 86,000,000 increased equity.
- Other comprehensive income increased equity by 15,995,000,000.
- Other factors decreased equity by 18,010,000,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $5.46 Billion | +11.58% |
| Dividends Paid | $1.65 Billion | -3.5% |
| Share Repurchases | $1.99 Billion | -4.23% |
| Share Issuances | $86.00 Million | +0.18% |
| Other Comprehensive Income | $15.99 Billion | +33.91% |
| Other Changes | $-18.01 Billion | -38.19% |
| Total Change | $- | -0.24% |
Book Value vs Market Value Analysis
This analysis compares Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.93x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.85x to 0.93x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $0.70 | $2.00 | x |
| 2019-12-31 | $0.77 | $2.00 | x |
| 2020-12-31 | $2.07 | $2.00 | x |
| 2021-12-31 | $2.21 | $2.00 | x |
| 2022-12-31 | $2.04 | $2.00 | x |
| 2023-12-31 | $2.15 | $2.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.58%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 29.65%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 18.69x
- Recent ROE (11.58%) is above the historical average (6.81%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 2.90% | 9.33% | 0.02x | 17.56x | $-3.46 Billion |
| 2015 | 1.85% | 5.18% | 0.02x | 17.31x | $-3.80 Billion |
| 2016 | 4.30% | 12.43% | 0.02x | 17.03x | $-2.74 Billion |
| 2017 | 7.78% | 21.46% | 0.02x | 16.61x | $-1.08 Billion |
| 2018 | 8.62% | 23.17% | 0.02x | 15.98x | $-690.50 Million |
| 2019 | 5.90% | 4.98% | 0.06x | 20.00x | $-2.27 Billion |
| 2020 | 2.68% | 8.71% | 0.02x | 17.71x | $-3.60 Billion |
| 2021 | 10.93% | 35.43% | 0.02x | 16.75x | $492.30 Million |
| 2022 | 11.55% | 29.98% | 0.02x | 18.57x | $731.30 Million |
| 2023 | 11.58% | 29.65% | 0.02x | 18.69x | $743.60 Million |
Industry Comparison
This section compares Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $21,282,152,580
- Average return on equity (ROE) among peers: 31.25%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lloyds Banking Group plc 9.25% NON-CUM IRR PRF SHS GBP0.25 (LLOBF) | $46.42 Billion | 2.90% | 18.41x | $18.85K |
| Arçelik Anonim Sirketi (ACKAF) | $59.56 Billion | 12.87% | 3.33x | $19.95K |
| Argo Group US Inc. 6.5% SR NTS 42 (ARGD) | $1.23 Billion | -15.51% | 0.05x | $232.01K |
| American Crystal Sugar Company PFD REST NON DIV (ASCS) | $316.55 Million | 254.25% | 1.77x | $54.72 Million |
| Autobacs Seven Co. Ltd (ATBSF) | $127.35 Billion | 4.24% | 0.47x | $167.34K |
| Brookfield Asset Management Inc FR PRF PERPETUAL CAD 25 Ser 2 Cls A (BKFAF) | $11.77 Billion | 6.69% | 3.72x | $76.46K |
| Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) | $5.08 Billion | 14.69% | 0.67x | $9.45 Million |
| BOL Bancshares Inc. PFD (BOLBP) | $11.94 Million | 0.62% | 6.68x | $0.91 |
| NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO) | $3.36 Billion | 11.17% | 0.52x | $237.68K |
| Canadian Utilities Limited 2ND PFD SER Y (CNAUF) | $4.14 Billion | 10.45% | 1.28x | $142.90K |
| Central Parking Finance Trust PFD TR CV SECS (CRLKP) | $374.10 | 13.04% | 2.96x | $224.78K |